- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Blood Lipid Profiles in United Kingdom
Total 37930 results
-
Genzyme, a Sanofi CompanyCompletedFamilial HypercholesterolemiaNetherlands, France, Germany, Sweden, United Kingdom
-
Wake Forest University Health SciencesCompletedLipid DisorderUnited States
-
Cambridge University Hospitals NHS Foundation TrustMedical Research Council; National Institute for Health Research, United KingdomRecruitingGaucher Disease, Type III | Gaucher Disease, Type IUnited Kingdom
-
Boehringer IngelheimCompletedHIV Infections | Metabolism, LipidsNetherlands, United Kingdom
-
University of ExeterWithdrawnHealthy | Lipodystrophy, Familial PartialUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseUnited States, France, Poland, United Kingdom
-
Genzyme, a Sanofi CompanyTerminatedFabry Disease | Alpha Galactosidase A DeficiencyUnited States, Austria, United Kingdom
-
Cerenis Therapeutics, SACompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Netherlands, United Kingdom
-
Amicus TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom
-
Alexion PharmaceuticalsCompletedWolman Disease | Lysosomal Acid Lipase DeficiencyUnited Kingdom, France, United States, Egypt, Ireland
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky DiseaseUnited States, Italy, Germany, United Kingdom
-
University of Colorado, DenverNational Institutes of Health (NIH)RecruitingBlood Pressure | Vascular Stiffness | Lipid Disorder | Appetitive Behavior | Gender Identity | Transgender | Vascular InflammationUnited States
-
Queen Mary University of LondonCompletedObesity | Insulin Resistance | Gestational Diabetes | High Blood Pressure | Pre-eclampsia | Stillbirth | Small for Gestational Age | Raised LipidsUnited Kingdom
-
National Eye Institute (NEI)CompletedNiemann Pick DiseasesUnited States, United Kingdom
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, United States
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Australia, France, United Kingdom, Brazil, Canada
-
Prevail TherapeuticsEli Lilly and CompanyActive, not recruitingGaucher Disease, Type 2United States, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
Mayo ClinicCompleted
-
Silence Therapeutics plcMedpace, Inc.CompletedDyslipidemias | Hyperlipidemias | Elevated Lp(a)United States, Australia, United Kingdom, Netherlands
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
Eli Lilly and CompanyCompletedDyslipidemiaUnited States, Netherlands, Germany, Denmark, Poland, United Kingdom
-
Alexion PharmaceuticalsCompletedLysosomal Acid Lipase Deficiency | Cholesterol Ester Storage Disease(CESD) | LAL-DeficiencyFrance, United States, United Kingdom, Czechia
-
Amicus TherapeuticsCompletedFabry DiseaseUnited Kingdom, United States
-
Amicus TherapeuticsTerminatedFabry DiseaseUnited Kingdom, United States, Australia, Brazil, France
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingLipid Metabolism DisordersUnited States
-
University of PennsylvaniaCompletedIn Need of a Pap Smear (Cervical Cancer Screening) | In Need of a Blood Pressure Check (Hypertension Screening) | In Need of a Cholesterol Test (Lipid Disorder Screening) | In Need of a Fasting Plasma Glucose Test (Diabetes)United States
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
Texas Woman's UniversityCompletedHypertension | DyslipidemiaUnited States
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingLipid Metabolism DisorderUnited States
-
The Touro College and University SystemUniversity of Vienna; Osato Research Institute; University of Mauritius; Mauritius... and other collaboratorsCompletedAssess the Effect of Green Tea on Diabetes | Assess the Effect of Fermented Papaya Pretration on Diabetes | Effects of Green Tea and FPP on C-reactive Proteins | Effects of Green Tea and FPP of Lipid Profiles in Diabetes | Effect of Green Tea and FPP on Atheroma FormationAustria, Mauritius, United States
-
University of PennsylvaniaActive, not recruiting
-
Arbutus Biopharma CorporationTerminated
-
ShireCompletedFabry DiseaseUnited States, Slovenia, Australia, Finland, Poland, Czechia, United Kingdom
-
University of PennsylvaniaAmarin Pharma Inc.CompletedDyslipidemias | Lipid Disorder | Triglycerides HighUnited States
-
Vanderbilt UniversityCompleted
-
University of Mississippi Medical CenterCompletedBlood Pressure | Oxidative Stress | HyperlipidemiaUnited States
-
HanAll BioPharma Co., Ltd.CompletedHypertension | HyperlipidemiaUnited States
-
University Hospital Birmingham NHS Foundation TrustNorthern Care Alliance NHS Foundation Trust; Cambridge University Hospitals... and other collaboratorsActive, not recruitingArrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry Disease (RaILRoAD)Fabry DiseaseUnited Kingdom, Australia
-
University of PennsylvaniaRecruiting
-
UCSF Benioff Children's Hospital OaklandDairy Management Inc.CompletedCardiovascular Disease | Dyslipidemia | Blood PressureUnited States
-
Purdue UniversityCompletedHypertension | DyslipidemiasUnited States
-
Jazz PharmaceuticalsCompletedDiabetes Mellitus, Type 2 | DyslipidemiasUnited Kingdom
-
Yale UniversityWithdrawnHypertension | HyperlipidemiasUnited States
-
Genzyme, a Sanofi CompanyCompletedSphingomyelin LipidosisBrazil, France, Italy, United States, Germany, United Kingdom
-
University of PennsylvaniaPassage Bio, Inc.RecruitingGM1 GangliosidosisUnited States, Turkey, Brazil, Canada, United Kingdom
-
Translational Research Center for Medical Innovation...RecruitingNeutral Lipid Storage DiseaseChina, United States, France, Austria, Germany, Italy, Japan, Netherlands, United Kingdom
-
NewAmsterdam PharmaUniversity of PennsylvaniaRecruiting